Final Program

152 MONDAY • MAY 16
1015 Resveratrol Can Improve Chronic Hypoxia Induced Pulmonary
Hypertension Only in Absence of Sirtuin 1 Catalytic Activity/
M. Taha, Y. Deng, M. McBurney, D.J. Stewart, Ottawa, Canada,
p.A3066
1016 Endosomal Proteins p18 and Rab4 Are Differentially Regulated
in Pulmonary Hypertension and COPD/Emphysema/H.
Chichger, A. Vang, Q. Lu, G. Choudhary, E.O. Harrington,
Cambridge, United Kingdom, p.A3067
1017 Epigenetic Regulation of the Anti-Proliferative Transient
Receptor Potential Melastatin 8 (TRPM8) Channels of
Pulmonary Arterial Smooth Muscle Cells in Hypoxic
Pulmonary Hypertension/J.S.K. Sham, O. Paudel, W.-Y. Tang,
Baltimore, MD, p.A3068
1018 Plasma Levels of Angiopoietin-2 in COPD: Effects of Smoking
and Pulmonary Hypertension/V.I. Peinado, J. Garcia-Lucio, T.
Paul, O. Tura, I. Blanco, J.A. Barbera, Barcelona, Spain, p.A3069
1019 RASSF1A Regulates ROS-HIF Axis in Hypoxia Driven
Pulmonary Hypertension/S. Dabral, C. Muecke, M. Schmoranzer,
C. Valsarajan, A. Weitelmann, R. Savai, W. Seeger, R. Dammann,
S.S. Pullamsetti, Bad Nauheim, Germany, p.A7808
B28
POSTER DISCUSSION SESSION
ADVANCES IN STEM CELLS IN INJURY AND
REPAIR FOR 2016
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2014 (West Building, Level 2)
Poster Viewing 9:00-9:45
Discussion 9:45-11:00
501 Human Bone Marrow Derived Mesenchymal Stem Cells and
Their Released Microvesicles May Promote the Resolution of
Acute Lung Injury in Mice in Part Through Inhibition of
Multidrug Resistance-Associated Protein 1/Q. Hao, V. Gudapati,
A. Monsel, H. Lim, J.-W. Lee, San Francisco, CA, p.A3070
502 Generation of Purified Human Type II Alveolar Cells from
Gene-Edited Pluripotent Stem Cells/A. Jacob, F. Hawkins, K.
Benson, M. Serra, D.N. Kotton, Boston, MA, p.A3071
503 Mesenchymal Stem Cells Drive Cell Repopulation In an In Vivo
Model of Lung Regeneration/J. Sembrat, C. Caufield, N.
Cardenes, R.R. Vanderpool, M. Bennewitz, S. Snovida, P. Sundd,
M. Rojas, Pittsburgh, PA, p.A3072
504 The Role of BMP Signaling in Deriving Endothelial Cells from
Human Pluripotent Stem Cells/M. Jamal, N. Ruopp, N. Prasain,
J.C. Jean, E.D. Austin, S. Majka, M. Yoder, D.N. Kotton, Boston,
MA, p.A3073
505 Human Umbilical Cord Mesenchymal Stromal/Stem Cells
Reduce Lung Injury in Rodent E. Coli Pneumonia by
Modulating Innate Immunity/M. Jerkic, A. Wolchuk, S. Dixon, G.
Hogan, X. Xu, C. Masterson, G.F. Curley, J.G. Laffey, Toronto,
Canada, p.A3074
506 Bone Marrow Derived Human Mesenchymal Stem Cells
Exposed to Pro-Inflammatory Cytokines Lose their
Mesenchymal Marker Expression and Transform into Cells
with Antigen Presenting Cell Gene Expression Patterns/M.
Schwede, E.M. Wilfong, C.S. Calfee, M. Matthay, San Francisco,
CA, p.A3075
507 Characterizing Embryonic Stem Cell Derived Multipotent Lung
Stem Cells/A. Kidiyoor, S. Murphy, A. Atala, Winston Salem, NC,
p.A3076
508 Human Bone Marrow-Derived Mesenchymal Stem Cells May
Modulate TLR4 Signaling to Favorably Affect Human Alveolar
Type II Cell Function in an In Vitro Model of Acute Lung
Injury/E.M. Wilfong, M. Schwede, X. Fang, J.W. Lee, C.S. Calfee,
M.A. Matthay, San Francisco, CA, p.A3077
509 Patient-Derived Airway Stem Cells in Human Lung
Bio-Engineering/S.E. Gilpin, J.M. Charest, L.F. Tapias, X. Ren, T.
Wu, D.J. Mathisen, H.C. Ott, Boston, MA, p.A3078
510 Mesenchymal Stem Cells Attenuate Hypoxia-Induced Pulmonary
Epithelial Injury Via an NF-kB Dependent Paracrine Mechanism/N.
Shologu, D. O’Toole, M. Scully, J. Laffey, Galway, Ireland, p.A3079
511 Forkhead BOX F1 Is a Novel Regulator of Autotaxin and
Modulates Migration of Human Lung-Resident Mesenchymal
Stem Cells/P. Cao, N. Walker, S. Mazzoni, Y. Aoki, V. Lama, Ann
Arbor, MI, p.A3080
512 Modified Mesenchymal Stem Cells Using miRNA Transfection
Could Modify Lung Fibrosis Progression/J. Sellares, L. Huleihel,
N. Cardenes, D. Alvarez, K. Sakamoto, G. Yu, M. Kapetanaki, N.
Kaminski, M. Rojas, Pittsburgh, PA, p.A3081
513 Characteristics of Mesenchymal Stem Cells from Swine with
and Without Acute Respiratory Distress Syndrome/B. Antebi,
R.K. Montgomery, K.P. Walker, J.S. McDaniel, A.T. Dixon, A.P.
Cap, L.C. Cancio, A.I. Batchinsky, Fort Sam Houston, TX, p.A3082
514 Polyunsaturated Fatty Acids Potentiate the Effects of
Mesenchymal Stromal Cells in Sepsis-Induced Acute
Respiratory Distress Syndrome/J.D. Silva, J.Z. Kitoko, L.L.
Castro, S.A.A. Trivelin, B.L. Diaz, P. Olsen, M.M. Morales, P.R.M.
Rocco, Rio de Janeiro, Brazil, p.A3083
515 Deficiencies in Mesenchymal Stem Cells from Idiopathic
Pulmonary Fibrosis Patients Result in Lower Capacity to
Protect the Lung from Injury/N. Cardenes, D. Alvarez, C. Corey,
S. Wecht, J. Sembrat, V.S. Hanumanthu, M. Bueno, J.S. Nine, S.
Shiva, M. Armanios, A.L. Mora, M. Rojas, Pittsburgh, PA, p.A3084
516 A Role for Mesenchymal Cell Telomerase Reverse
Transcriptase in Pulmonary Fibrosis/T. Liu, H. Yu, L. Ding, Z.
Wu, F. Gonzalez De Los Santos, J. Liu, M. Ullenbruch, B. Hu, V.
Martins, S.H. Phan, Ann Arbor, MI, p.A3085
517 Dependence of Lung Epithelial Stem Cell Proliferation and
Differentiation on Fibroblast-Specific FGF2 Signaling/M. Ozaki,
A. Hegab, R. Guzy, D. Ornitz, T. Betsuyaku, Tokyo, Japan,
p.A3086
518 Alveolar Epithelial Type II Cell-Specific Deletion of Foxo1
Results in Increased Stem/Progenitor Cell Proliferation In
Vitro/Y. Yeragunta, D.R. Castillo, M. Rieger, J.M. Liebler, P.
Flodby, B. Zhou, E.D. Crandall, Z. Borok, Los Angeles, CA,
p.A3087
ATS 2016 • San Francisco